Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Terminated

GemStar Docking Station, used with GemStar infusion pump, in combination with other GemStar accessories such as the GemStar Lock Box and patient bolus cord. The docking station is also used for hosting the GemStar pump for general infusions. List Numbers: 13075-XX-XX.

FDA Recall Z-1512-2014 · Posted 2014-05-01

Recalling FirmHospira Inc.
Recall StatusTerminated
Product CodeFRN
Date Initiated2014-02-18
Date Terminated2017-01-23
Product Quantity26,765 docking stations total (6866 in US)

Reason for Recall

There are two situations that may occur when using the GemStar Docking Station, List Number 13075-XX-XX, in conjunction with the GemStar infusion pump: 1) when the Docking Station is used in conjunction with a GemStar Phase 3 pump (List 13000-XX, 13100-XX, or 13150-XX) the potential exists for the GemStar Phase 3 pump to fail to power up while connected to the Docking Station, and 2) when either a GemStar Phase 3 (List 13000-XX, 13100-XX, or 13150-XX)or GemStar Phase 4 pump (List 13086-XX, 13087-XX, or 13088-XX) is used in conjunction with both a Docking Station and an External Battery Pack accessory (List 13073-XX) there exists a possibility that the GemStar pump will display error code 11/003 and give an audible alarm indicating excessive input voltage from the external sources. If the GemStar pump detects what is perceived to be more than 3.6 Volts measured on the external voltage input, the pump will stop the infusion and alarm both with an audible sound as well as a visual alarm.

Firm Action

Hospira sent an URGENT MEDICAL DEVICE CORRECTION letter dated February 18, 2014, to all affected customers. The letter identified the product, the problem, and the action to be taken by the customer. The letter included the following instructions: 1) To avoid failure to power up, turn the pump on first, before connecting the pump with the docking station. This will prevent the failure to power up. 2) To mitigate the potential for an 11/003 error code, remove the External Battery Pack accessory (List 13073) from the Docking Station in conjunction with an External Battery Pack accessory (List 13073), this practice should not continue. Please contact Hospira to discuss an appropriate alternative. Additional instructions included: 1) Inform potential users within the recipient's organization of the notification. 2) Should the facility experience a failure to power up or an 11/003 error code, report the issue to Hospira by calling 1-800-441-4100 (Monday - Friday, 8:00 AM - 5:00 PM CT) or e-mail [email protected]. 3) Compelte the attached reply form and return it to the fax number or e-mail address on the firm, even if there is no affected product in inventory. 4) If th products were further distributed, notify the accounts that received the products identified in the notification and ask them to contact Steriycle at 866-792-5451 (Monday - Friday, 8:00 AM - 5:00 PM ET) to receive a reply form. For questions regarding this recall call 800-441-4100.

Root Cause

Device Design

Distribution Pattern

Worldwide Distribution - USA including AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY, District of Columbia, Guam, Puerto Rico, and Internationally to Australia, Austria, Bahrain, Belgium, Canada, Chile, Egypt, France, Germany, Greece, Hong Kong, Italy, Jordan, Kuwait, Lebanon, Libya, Luxemburg, Netherlands, New Zealand, Oman, Portugal, Saudi Arabia, Slovenia, South Africa, Spain, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Related FDA 510(k) Records

Devices referenced by this recall via K-numbers.

Official Source

View FDA Recall →

Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.

↑